<VariationArchive RecordType="classified" VariationID="997800" VariationName="NC_000023.10:g.(31697577_31747779)_(31986532_32235089)del" VariationType="Deletion" Accession="VCV000997800" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-03-18" DateCreated="2021-02-28" MostRecentSubmission="2021-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="985515" VariationID="997800">
      <GeneList>
        <Gene Symbol="DMD" FullName="dystrophin" GeneID="1756" HGNC_ID="HGNC:2928" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp21.2-21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="31119222" stop="33339388" display_start="31119222" display_stop="33339388" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="31137344" stop="33357725" display_start="31137344" display_stop="33357725" Strand="-" />
          </Location>
          <OMIM>300377</OMIM>
          <Haploinsufficiency last_evaluated="2019-11-20" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DMD">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-11-20" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DMD">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000023.10:g.(31697577_31747779)_(31986532_32235089)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" outerStart="31697577" innerStart="31747779" innerStop="31986532" outerStop="32235089" display_start="31697577" display_stop="32235089" variantLength="238754" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.(31697577_31747779)_(31986532_32235089)del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.(31697577_31747779)_(31986532_32235089)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <FunctionalConsequence Value="exon loss">
        <XRef ID="0381" DB="Variation Ontology" />
      </FunctionalConsequence>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000023.10:g.(31697577_31747779)_(31986532_32235089)del AND Duchenne muscular dystrophy" Accession="RCV001293353" Version="1">
        <ClassifiedConditionList TraitSetID="3094">
          <ClassifiedCondition DB="MedGen" ID="C0013264">Duchenne muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-02-28" MostRecentSubmission="2021-02-28">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3094" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10877" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Duchenne muscular dystrophy</ElementValue>
                <XRef ID="Duchenne+Muscular+Dystrophy/2340" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010679" DB="MONDO" />
                <XRef ID="76670001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, pseudohypertrophic progressive, Duchenne type</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DMD</ElementValue>
                <XRef Type="MIM" ID="310200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6291" />
                <XRef ID="6291" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The dystrophinopathies cover a spectrum of X-linked muscle disease ranging from mild to severe that includes Duchenne muscular dystrophy, Becker muscular dystrophy, and DMD-associated dilated cardiomyopathy (DCM). The mild end of the spectrum includes the phenotypes of asymptomatic increase in serum concentration of creatine phosphokinase (CK) and muscle cramps with myoglobinuria. The severe end of the spectrum includes progressive muscle diseases that are classified as Duchenne/Becker muscular dystrophy when skeletal muscle is primarily affected and as DMD-associated DCM when the heart is primarily affected. Duchenne muscular dystrophy (DMD) usually presents in early childhood with delayed motor milestones including delays in walking independently and standing up from a supine position. Proximal weakness causes a waddling gait and difficulty climbing stairs, running, jumping, and standing up from a squatting position. DMD is rapidly progressive, with affected children being wheelchair dependent by age 12 years. Cardiomyopathy occurs in almost all individuals with DMD after age 18 years. Few survive beyond the third decade, with respiratory complications and progressive cardiomyopathy being common causes of death. Becker muscular dystrophy (BMD) is characterized by later-onset skeletal muscle weakness. With improved diagnostic techniques, it has been recognized that the mild end of the spectrum includes men with onset of symptoms after age 30 years who remain ambulatory even into their 60s. Despite the milder skeletal muscle involvement, heart failure from DCM is a common cause of morbidity and the most common cause of death in BMD. Mean age of death is in the mid-40s. DMD-associated DCM is characterized by left ventricular dilation and congestive heart failure. Females heterozygous for a DMD pathogenic variant are at increased risk for DCM.</Attribute>
                <XRef ID="NBK1119" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="general" Abbrev="Updated, AAN/CNS, 2005">
                <ID Source="PubMed">15642897</ID>
              </Citation>
              <Citation Type="general" Abbrev="AAP, 2005">
                <ID Source="PubMed">16322188</ID>
              </Citation>
              <Citation Type="general" Abbrev="DMD Management and Anesthesia - ACCP, 2007">
                <ID Source="PubMed">18079231</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2010">
                <ID Source="PubMed">19945913</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2010">
                <ID Source="PubMed">19945914</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301298</ID>
                <ID Source="BookShelf">NBK1119</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301604</ID>
                <ID Source="BookShelf">NBK1431</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC Respiratory Panel, 2010">
                <ID Source="PubMed">20597083</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2013">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_DuchenneMuscularDystrophy-enPro13913.pdf</URL>
                <CitationText>Orphanet, Duchenne muscular dystrophy, 2013</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="AAN, 2022">
                <ID Source="PubMed">26833937</ID>
                <ID Source="pmc">4773944</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2018">
                <ID Source="PubMed">29395990</ID>
                <ID Source="pmc">5889091</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2018">
                <ID Source="PubMed">29398641</ID>
                <ID Source="pmc">5902408</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2018">
                <ID Source="PubMed">29395989</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/DMD_Pathogenic_Variants.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Pathogenic Variant in Dystrophin (DMD Gene) and elevated creatine kinase muscle isoform (CK-MM), Duchenne and Becker Muscular Dystrophy, 2019</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2020">
                <URL>https://www.acmg.net/PDFLibrary/DMD_CKMM.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated creatine kinase muscle isoform (CKMM), Genetic Neuromuscular Disease, 2020</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/DMD-Elevated-CKMM-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, ELEVATED CREATINEKINASE(CK)-MM , Genetic Neuromuscular Disorders, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2020">
                <URL>https://www.acmg.net/PDFLibrary/DMD_No_Pathogenic_Variant.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, No Pathogenic Variant in Dystrophin (DMD) Gene after elevated creatine kinase muscle isoform (CK-MM), Genetic Neuromuscular Disease, 2020</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Duchenne-Becker-Muscular-Dystrophy.pdf</URL>
                <CitationText>American College of Medical Genetics &amp;amp; Genomics Genetic Testing ACT Sheet, Duchenne and Becker Muscular Dystrophy, 2012</CitationText>
              </Citation>
              <XRef ID="98896" DB="Orphanet" />
              <XRef ID="C0013264" DB="MedGen" />
              <XRef ID="MONDO:0010679" DB="MONDO" />
              <XRef Type="MIM" ID="310200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2921073" SubmissionDate="2021-02-23" DateLastUpdated="2021-02-28" DateCreated="2021-02-28">
        <ClinVarSubmissionID localKey="SUB9093974" submittedAssembly="GRCh38" title="SUB9093974" />
        <ClinVarAccession Accession="SCV001480030" DateUpdated="2021-02-28" DateCreated="2021-02-28" Type="SCV" Version="1" SubmitterName="Department of Neurogenetics, Institute for Communicative and Cognitive Neurosciences" OrgID="507952" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Ethnicity>South Indian</Ethnicity>
              <GeographicOrigin>India</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
              <Indication Type="Indication">
                <Trait Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Muscular dystrophy</ElementValue>
                  </Name>
                </Trait>
              </Indication>
            </Sample>
            <Method>
              <Description>Multiplex ligation-dependent probe amplification</Description>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Curated</Attribute>
              </MethodAttribute>
              <MethodAttribute>
                <Attribute Type="TestName">MLPA</Attribute>
              </MethodAttribute>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory">Eugene</Attribute>
                <Comment>Pathogenic</Comment>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DMD">
              <Name>dystrophin</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">LOVD:DMD_014552</Name>
          </OtherNameList>
          <FunctionalConsequence Value="exon loss">
            <XRef DB="Variation Ontology" ID="0381" URL="http://purl.obolibrary.org/obo/VariO_0381" />
          </FunctionalConsequence>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(31697577_31747779)_(31986532_32235089)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="310200" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9093974</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2921073" TraitType="Disease" MappingType="XRef" MappingValue="310200" MappingRef="OMIM">
        <MedGen CUI="C0013264" Name="Duchenne muscular dystrophy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

